Advertisement

HindustanTimes Sun,21 Sep 2014

Dr Reddy's Q3 net dips 29% to Rs.363.3 cr

HT Correspondent, Hindustan Times  Mumbai, February 14, 2013
First Published: 22:24 IST(14/2/2013) | Last Updated: 22:25 IST(14/2/2013)

Drug maker Dr Reddy's Laboratories on Thursday announced a decline of 29% year-on-year in its net profit to Rs.363.3 crore for the third quarter ended December 2012 against Rs.512.96 crore a year ago.

Advertisement

The company's research and development expenses rose 34% to Rs.203 crore while selling general and administrative expenses were up over 11.5% at Rs.857 crore.

Its shares declined 1% to close at Rs.1,878 on the BSE.


Advertisement
more from Business

Airlines oppose govt policy on connectivity to remote areas

Airlines and private charter operators have opposed the government's draft policy on air connectivity to regional and remote areas, saying it will have severe impact on their financial strength.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved